L M Wuescher1, A Takashima, R G Worth. 1. Department of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Abstract
BACKGROUND: Platelets are critical cells for maintaining vascular hemostasis, but their activities in other processes are becoming apparent. Specifically, the ability of platelets to recognize and respond to infectious agents is an important area of investigation. To understand the physiologic roles of platelets in vivo, most researchers have used antibody-mediated platelet depletion, which has certain limitations. OBJECTIVE: To develop an optimal system with which to study the contribution of platelets to protection against S. aureus blood infection. METHODS: Here, we describe a novel experimental model of conditional platelet depletion based on the Cre-recombinase cell ablation system. With this technology, the simian diphtheria toxin receptor was expressed in platelet factor 4-positive cells (megakaryocytes and platelets). RESULTS: Systemic administration of diphtheria toxin every 48 h resulted in reduced platelet numbers that became undetectable after 6 days. Although platelets were depleted, no other blood cells were affected. With this newly developed model, the functional contributions of platelets to protection against Staphylococcus aureus bacteremia was examined. Platelet-depleted mice succumbed to infection more rapidly than wild-type mice, and had a significantly higher bacterial burden in kidneys, elevated levels of serum markers of kidney damage, and increased levels of cytokines indicative of septic shock. CONCLUSIONS: Here, we illustrate a new mouse model for conditional platelet depletion, and implicate platelets as important participants in the immune response to bacterial blood infections.
BACKGROUND: Platelets are critical cells for maintaining vascular hemostasis, but their activities in other processes are becoming apparent. Specifically, the ability of platelets to recognize and respond to infectious agents is an important area of investigation. To understand the physiologic roles of platelets in vivo, most researchers have used antibody-mediated platelet depletion, which has certain limitations. OBJECTIVE: To develop an optimal system with which to study the contribution of platelets to protection against S. aureus blood infection. METHODS: Here, we describe a novel experimental model of conditional platelet depletion based on the Cre-recombinase cell ablation system. With this technology, the simian diphtheria toxin receptor was expressed in platelet factor 4-positive cells (megakaryocytes and platelets). RESULTS: Systemic administration of diphtheria toxin every 48 h resulted in reduced platelet numbers that became undetectable after 6 days. Although platelets were depleted, no other blood cells were affected. With this newly developed model, the functional contributions of platelets to protection against Staphylococcus aureus bacteremia was examined. Platelet-depleted mice succumbed to infection more rapidly than wild-type mice, and had a significantly higher bacterial burden in kidneys, elevated levels of serum markers of kidney damage, and increased levels of cytokines indicative of septic shock. CONCLUSIONS: Here, we illustrate a new mouse model for conditional platelet depletion, and implicate platelets as important participants in the immune response to bacterial blood infections.
Authors: M Saito; T Iwawaki; C Taya; H Yonekawa; M Noda; Y Inui; E Mekada; Y Kimata; A Tsuru; K Kohno Journal: Nat Biotechnol Date: 2001-08 Impact factor: 54.908
Authors: Binggang Xiang; Guoying Zhang; Ling Guo; Xiang-An Li; Andrew J Morris; Alan Daugherty; Sidney W Whiteheart; Susan S Smyth; Zhenyu Li Journal: Nat Commun Date: 2013 Impact factor: 14.919
Authors: Yacine Boulaftali; Paul R Hess; Todd M Getz; Agnieszka Cholka; Moritz Stolla; Nigel Mackman; A Phillip Owens; Jerry Ware; Mark L Kahn; Wolfgang Bergmeier Journal: J Clin Invest Date: 2013-01-25 Impact factor: 14.808
Authors: Marie-Luise von Brühl; Konstantin Stark; Alexander Steinhart; Sue Chandraratne; Ildiko Konrad; Michael Lorenz; Alexander Khandoga; Anca Tirniceriu; Raffaele Coletti; Maria Köllnberger; Robert A Byrne; Iina Laitinen; Axel Walch; Alexander Brill; Susanne Pfeiler; Davit Manukyan; Siegmund Braun; Philipp Lange; Julia Riegger; Jerry Ware; Annekathrin Eckart; Selgai Haidari; Martina Rudelius; Christian Schulz; Katrin Echtler; Volker Brinkmann; Markus Schwaiger; Klaus T Preissner; Denisa D Wagner; Nigel Mackman; Bernd Engelmann; Steffen Massberg Journal: J Exp Med Date: 2012-03-26 Impact factor: 14.307
Authors: Jialie Luo; Jing Feng; Guang Yu; Pu Yang; Madison R Mack; Junhui Du; Weihua Yu; Aihua Qian; Yujin Zhang; Shenbin Liu; Shijin Yin; Amy Xu; Jizhong Cheng; Qingyun Liu; Roger G O'Neil; Yang Xia; Liang Ma; Susan M Carlton; Brian S Kim; Kenneth Renner; Qin Liu; Hongzhen Hu Journal: J Allergy Clin Immunol Date: 2017-08-11 Impact factor: 10.793
Authors: Kathleen M Overholt; Satoru Otsuru; Timothy S Olson; Adam J Guess; Victoria M Velazquez; Laura Desbourdes; Massimo Dominici; Edwin M Horwitz Journal: Blood Adv Date: 2017-12-14
Authors: Thayer K Darling; Michael P Schenk; Chengjing C Zhou; Franklin M Maloba; Patrice N Mimche; Jonathan M Gibbins; Shawn M Jobe; Tracey J Lamb Journal: Blood Adv Date: 2020-01-14
Authors: Jan Rossaint; Katharina Thomas; Sina Mersmann; Jennifer Skupski; Andreas Margraf; Tobias Tekath; Charlotte C Jouvene; Jesmond Dalli; Andres Hidalgo; Sven G Meuth; Oliver Soehnlein; Alexander Zarbock Journal: J Exp Med Date: 2021-05-20 Impact factor: 14.307
Authors: Samantha G Palace; Olga Vitseva; Megan K Proulx; Jane E Freedman; Jon D Goguen; Milka Koupenova Journal: J Thromb Haemost Date: 2020-09-20 Impact factor: 5.824